By the time Australia is ready to deliver Novavax, we may well have completed most of the vaccine rollout with AstraZeneca, Pfizer and Moderna. That doesn’t mean Novavax won’t play an important role.
Marios Koutsakos, The Peter Doherty Institute for Infection and Immunity
Scientists around the world are trying to come up with universal coronavirus vaccines to combat the emergence of variants. But what are these vaccines and are they even possible?
Sheena G. Sullivan, WHO Collaborating Centre for Reference and Research on Influenza and Kanta Subbarao, The Peter Doherty Institute for Infection and Immunity
Decades of experience with influenza offers insights into how we should handle new SARS-CoV-2 variants, and the threat they pose to vaccine effectiveness.
Whether an employer can insist on vaccination as a condition of employment is an ambiguous legal question, as shown by two recent unfair dismissal cases.
You need a new shot every year because current flu vaccines provide limited and temporary protection. But researchers’ new strategy could mean a one-and-done influenza vaccine is on the way.
Employers could require their workers to get vaccinated against COVID-19 via both workplace policies and existing laws. Neither option, however, is simple or straightforward.
Millions of Latinos may not get the influenza shot this year, which could be an indicator of whether they will get a COVID-19 shot. A rural clinic shows how building trust can help overcome reluctance.
Once a coronavirus vaccine is approved, billions of doses need to be manufactured. Current vaccine production is nowhere near ready, for a variety of reasons, but planning now could help.
Those opposing vaccinations often mistrust government, science and the news media. There may be better ways to persuade them than by offering facts only.
Pandemic policy experts offer 10 recommendations that could reduce the risk that a bad flu season on top of the COVID-19 pandemic will overwhelm hospitals.
The flu vaccine will not protect you from getting COVID-19. But it will help avoid unnecessary doctors’ visits and protect vulnerable groups from potentially more severe disease.
In the 1980s, CSIRO and its university collaborators set into motion a chain of events that would lead to the production of relenza, the first drug to successfully treat the flu.
Karl Schmedders, International Institute for Management Development (IMD); Jung Park, International Institute for Management Development (IMD), and Robert Earle, University of Zurich
Starting to feel a little more optimistic? Look away now.
Getting vaccinated against the flu, washing your hands and social distancing are three ways you can help reduce the impact of both the flu and coronavirus.